Prognostic value of PD-L1 expression and CD68 macrophages in tumor nest of patients with primary gastric cancer

被引:3
|
作者
Zou, Yunlian [1 ,2 ]
Wang, Jinli [2 ,3 ]
Zhang, Jinping [1 ,2 ]
Guo, Qiang [2 ,3 ]
Song, Zhengji [2 ,3 ,4 ]
Tang, Hui [2 ,3 ,4 ]
机构
[1] Kunming Univ Sci & Technol, Peoples Hosp Yunnan Prov 1, Affiliated Hosp, Dept Hematol, Kunming 650032, Yunnan, Peoples R China
[2] Kunming Univ Sci & Technol, Med Fac, Kunming 650504, Yunnan, Peoples R China
[3] Kunming Univ Sci & Technol, Peoples Hosp Yunnan Prov 1, Dept Gastroenterol, Affiliated Hosp, Kunming 650032, Yunnan, Peoples R China
[4] Kunming Univ Sci & Technol, Peoples Hosp Yunnan Prov 1, Affiliated Hosp, Dept Gastroenterol, 157 Jinbi Rd, Kunming 650032, Yunnan, Peoples R China
基金
中国国家自然科学基金;
关键词
gastric cancer; multiplex immunohistochemistry; programmed death receptor ligand 1; cluster of differentiation 68; prognosis biomarker; DEATH-LIGAND; 1; INFILTRATING LYMPHOCYTES; SIGNIFICANT PREDICTOR; CD133; EXPRESSION; SURVIVAL; OVEREXPRESSION; PROGRESSION; CARCINOMA; PATHWAY; MARKER;
D O I
10.3892/ol.2023.14153
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The programmed death receptor 1/programmed death receptor ligand 1 axis (PD-1/PD-L1) is involved in tumor immune escape and is a potential prognostic biomarker and anti-tumor immunotherapy target in patients with gastric cancer (GC). However, the results of studies obtained in recent years have been inconsistent. The present study aimed to determine the possible predictive significance of PD-L1 in conjunction with three proteins linked with PD-L1 regulation in patients with primary GC. In the present study, the PD-L1, human epidermal growth factor receptor 2 (HER2), cluster of differentiation (CD)133 and microphage-associated CD68 expression levels were identified by multiplexed immunohistochemistry and assessed by automated pathological analysis system in 93 GC tumors and neighboring normal tissues arrayed on the same tissue microarray. All four proteins were statistically analyzed in relation to the clinicopathological characteristics. The expression levels of HER2, CD133 and CD68 were considerably higher in cancer tissues compared with neighboring normal tissues (P<0.05), however, the reverse trend was detected for PD-L1 expression (P=0.0577), particularly in tumor nest (TN; P<0.05). There was no significant correlation between the HER2 and CD133 expression levels and clinicopathological factors. However, significant relationships were found between PD-L1 expression and the TNM stage, pathological differentiation and survival status of patients (P<0.05). Moreover, survival time was prolonged in individuals with elevated PD-L1 expression in TN and GC tissues, but no significant correlation was identified (P=0.0881). The CD68 expression level in tumor stroma, but not in TN, was significantly correlated with poor pathological differentiation in patients with GC (P<0.05). However, PD-L1+CD68+ macrophages were strongly related to lower tumor size (diameter <5 cm), early TNM stage (stage I+II), good pathological differentiation and overall survival in TN (P<0.05). In conclusion, PD-L1+CD68+ macrophage infiltration in TN might be a potential indicator of prognosis in patients with primary GC and merits further investigation.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Prognostic and clinicopathological value of PD-L1 expression in primary breast cancer: a meta-analysis
    Huang, Wenfa
    Ran, Ran
    Shao, Bin
    Li, Huiping
    BREAST CANCER RESEARCH AND TREATMENT, 2019, 178 (01) : 17 - 33
  • [22] Prognostic and clinicopathological value of PD-L1 expression in primary breast cancer: a meta-analysis
    Wenfa Huang
    Ran Ran
    Bin Shao
    Huiping Li
    Breast Cancer Research and Treatment, 2019, 178 : 17 - 33
  • [23] Expression of tumor-associated macrophages and PD-L1 in patients with hepatocellular carcinoma and construction of a prognostic model
    Panpan kong
    Huan Yang
    Qing Tong
    Xiaogang Dong
    Mamumaimaitijiang-Abula Yi
    Dong Yan
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 10685 - 10700
  • [24] Expression of tumor-associated macrophages and PD-L1 in patients with hepatocellular carcinoma and construction of a prognostic model
    Kong, Panpan
    Yang, Huan
    Tong, Qing
    Dong, Xiaogang
    Yi, Mamumaimaitijiang-Abula
    Yan, Dong
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (12) : 10685 - 10700
  • [25] The prognostic value of PD-L1/PD-1 expression and PD-L1 gene copy number on/in tumor and immune cells in triple negative breast cancer
    Seitz, S.
    Brockhoff, G.
    Weber, F.
    Klinkhammer-Schalke, M.
    Zeman, F.
    Ugocsai, P.
    Ortmann, O.
    Wege, A.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 4 - 4
  • [26] Prognostic importance of PD-L1 expression in bladder cancer patients
    Durur, Sumeyye
    Uzun, Hakki
    Bedir, Recep
    Nalkiran, Ihsan
    Nalkiran, Hatice Sevim
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2023, 19 : S633 - S638
  • [27] Prognostic importance of PD-L1 expression in bladder cancer patients
    Durur, Sumeyye
    Uzun, Hakki
    Bedir, Recep
    Nalkiran, Ihsan
    Nalkiran, Hatice Sevim
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2023, 19 (SUPPL 2) : S633 - S638
  • [28] The comparison of PD-L1 expression in primary with metastatic sites in gastric cancer
    Toihata, Tasuku
    Iwatsuki, Masaaki
    Yamashita, Kouhei
    Koga, Yuki
    Kuroda, Daisuke
    Hiyoshi, Yukiharu
    Baba, Yoshifumi
    Miyamoto, Yuji
    Yoshida, Naoya
    Baba, Hideo
    CANCER SCIENCE, 2018, 109 : 1058 - 1058
  • [29] Prognostic value of tumor infiltrating lymphocytes combined with PD-L1 expression for patients with solitary colorectal cancer liver metastasis
    Xiao, Binyi
    Peng, Jianhong
    Wang, Yongchun
    Deng, Yuxiang
    Ou, Qingjian
    Wu, Xiaojun
    Lin, Junzhong
    Pan, Zhizhong
    Zhang, Lin
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (19)
  • [30] PD-L1 is an independent prognostic predictor in gastric cancer of Western patients
    Boeger, Christine
    Behrens, Hans-Michael
    Mathiak, Micaela
    Krueger, Sandra
    Kalthoff, Holger
    Roecken, Christoph
    ONCOTARGET, 2016, 7 (17) : 24269 - 24283